PMID: 41747885

Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes.

Bailey Clifford J, Flatt Peter R, Conlon J Michael

Peptides · 2026

Vol. 196, pp. 171480

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansDiabetes Mellitus, Type 2ObesityAnimalsIslet Amyloid PolypeptideSemaglutideAmylin Receptor AgonistsReceptors, Islet Amyloid PolypeptideGlucagon-Like PeptidesHypoglycemic Agents

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.